Coverage and predictors of influenza vaccination among adults with diabetes in Spain

Diabetes Research and Clinical Practice

Volumn 79, Issue 3, 2008, Pages 510-517

  Jiménez García, Rodrigo ^a   Jimenez, Isabel ^a   Garrido, Pilar Carrasco ^a   Hernández Barrera, Valentín ^a   de Andres, Ana Lopez ^a   del Barrio, Jose Luis ^a   de Miguel, Ángel Gil ^a  

^a Health Sciences Faculty   (Spain)

Author keywords

Epidemiology; Influenza; Trends; Vaccine

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; DEMOGRAPHY; DIABETES MELLITUS; EXERCISE; FEMALE; GENDER; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBESITY; RESPIRATORY TRACT DISEASE; SMOKING HABIT; SPAIN; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; FEMALE; HEALTH CARE SURVEYS; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SPAIN; VACCINATION;

EID: 39449096614     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.013     Document Type: Article

References (58)

1. Smith S.A., Poland G.A., and American Diabetes Association. Influenza and pneumococcal immunization in diabetes. Diabetes Care 27 (2004) S111-S113
2. Centers for Disease Control and Prevention. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP], MMWR 55 (2006) 1-44.
3. Smith S.A., and Poland G.A. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 23 (2000) 95-108
4. Pozzilli P., Gale E.A., Visalli N., Baroni M., Crovari P., Frighi V., et al. The immune response to influenza vaccination in diabetic patients. Diabetología 29 (1986) 850-854
5. Nichol K.L., Wuorenma J., and von Sternberg T. Benefits of influenza vaccination for low-intermediate-, and high-risk senior citizens. Arch. Intern. Med. 158 (1998) 1769-1776
6. Colquhoun A.J., Nicholson K.G., Botha J.L., and Raymond N.T. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol. Infect. 119 (1997) 335-341
7. Heymann A.D., Shapiro Y., Chodick G., Shalev V., Kokia E., Kramer E., et al. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care 27 (2004) 2581-2584
8. Voordouw A.C., Sturkenboom M.C., Dieleman J.P., Stijnen T., Smith D.J., van der Lei J., et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 292 (2004) 2089-2095
9. Looijmans-Van den Akker I., Verheij T.J., Buskens E., Nichol K.L., Rutten G.E., and Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 29 (2006) 1771-1776
10. Costa Tadeo X., Navarro Aznarez G., Campos Abellana C., Esporrin Bosque C., and Romero Ruiz A.I. [The evaluation of noncompliance in an anti-influenza vaccination program] Spanish. Aten Primaria 8 (1991) 544-546
11. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785
12. American Diabetes Association: Standards of Medical Care in Diabetes (Position Statement), Diabetes Care 28 (2005) S4-S36.
13. Guerin N. Assessing immunization coverage: how and why?. Vaccine 16 Suppl. (1998) S81-S83
14. LeBaron C.W., Chaney M., Baughman A.L., Dini E.F., Maes E., Dietz V., et al. Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA 277 (1997) 631-635
15. Kamal K.M., Madhavan S.S., and Amonkar M.M. Determinants of adult influenza and pneumonia immunization rates. J. Am. Pharm. Assoc. (Wash. DC) 42 (2003) 403-411
16. Kroneman M., Paget W.J., and van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro. Surveill. 8 (2003) 130-138
17. Chapman G.B., and Coups E.J. Predictors of influenza vaccine acceptance among healthy adults. Prev. Med. 29 (1999) 249-262
18. Egede L.E. Association between number of physician visits and influenza vaccination coverage among diabetic adults with access to care. Diabetes Care 26 (2003) 2562-2567
19. Okoro C.A., Mokdad A.H., Ford E.S., Bowman B.A., Vinicor F., and Giles W.H. Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System. Prev. Med. 38 (2004) 203-208
20. Centers for Disease Control. Influenza and pneumococcal vaccination rates among persons with diabetes mellitus-United States, 1997, MMWR Morb. Mortal. Wkly. Rep. 48 (1999) 961-967.
21. Centers for Disease Control. Preventive-care practices among persons with diabetes-United States, 1995 and 2001, MMWR Morb. Mortal. Wkly. Rep. 51 (2002) 965-969.
22. Centers for Disease Control. Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years-United States, 2002, MMWR Morb. Mortal. Wkly. Rep. 52 (2003) 987-992.
23. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged >65 years and persons aged 18-64 years with diabetes or asthma United States, 2003, MMWR Morb. Mortal. Wkly. Rep. 53 (2004) 1007-1012.
24. Garrow D., and Egede L.E. Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. Diabetes Care 29 (2006) 15-19
25. Centers for Disease Control and Prevention. Self-reported influenza vaccination coverage trends. Available from: http://www.cdc.gov/flu/professionals/vaccination/pdf/vaccinetrend.pdf. Accessed 29 September 2006.
26. Phillips M.M. Targeting diabetes preventive care programs: insights from the 2001 Behavioral. Risk Factor Surveillance Survey. Prev. Chronic Dis. 1 (2004) A07
27. Saaddine J.B., Cadwell B., Gregg E.W., Engelgau M.M., Vinicor F., Imperatore G., et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann. Intern. Med. 144 (2006) 465-474
28. Wahid S.T., Nag S., Bilous R.W., Marshall S.M., and Robinson A.C. Audit of influenza and pneumococcal vaccination uptake in diabetic patients attending secondary care. Diabet. Med. 18 (2001) 599-603
29. Sotiropoulos A., Merkouris P., Gikas A., Skourtis S., Skliros E., and Lanaras L. Ni. Influenza and pneumococcal vaccination rates among Greek diabetic patients in primary care. Diabet. Med. 22 (2005) 110-111
30. Jimenez-Garcia R., Mayo-Montero E., Hernandez-Barrera V., Garrido P.C., Martinez-Hernandez D., and de Miguel A.G. Influenza vaccination among diabetic adults: related factors and trend from 1993 to 2001 in Spain. Diabetes Care 28 (2005) 2031-2033
31. Lewis-Parmar H., and McCann R. Achieving national influenza vaccine targets-an investigation of the factors affecting influenza vaccine uptake in older people and people with diabetes. Commun. Dis. Public Health 5 (2002) 119-126
32. INE.Instituto Nacional de Estadística. Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Available from: http://www.ine.es/en/metodologia/t15/t1530419_en.pdf). Accessed 18 September 2006.
33. INE. Instituto Nacional de Estadística. Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Details on the evaluation of non respondents. Available from: (http://www.ine.es/daco/daco42/sanitarias/evaluacion.pdf). Accessed 18 September 2006.
34. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., and Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 22 (2004) 2163-2170
35. Nunes B., Contreiras T., and Falcao J.M. [Influenza vaccination: coverage of Portuguese population from 1998/1999 a 2002/2003] Portuguese. Rev. Port. Pneumol. 10 (2004) 115-123
36. Kroneman M., van Essen G.A., and John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 24 (2006) 622-628
37. Jimenez-Garcia R., Mayo-Montero E., Hernandez-Barrera V., Sierra-Moros M.J., Pachon del Amo I., Carrasco-Garrido P., et al. Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine 23 (2005) 44-50
38. Jimenez-Garcia R., Arinez-Fernandez M.C., Garcia-Carballo M., Hernandez-Barrera V., de Miguel A.G., and Carrasco-Garrido P. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 23 (2005) 3679-3686
39. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch. Intern. Med. 165 (2005) 274-280
40. Nichol K.L., and Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch. Intern. Med. 161 (2001) 2702-2708
41. Hak E., Hermens R.P., Hoes A.W., Verheij T.J., Kuyvenhoven M.M., and van Essen G.A. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scand. J. Prim. Health Care 18 (2000) 237-241
42. Centers for Disease Control and Prevention: Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults: a report on recommendations of the Task Force on Community Preventive Services, MMWR Morb. Mortal. Wkly. Rep. 48 (1999) 1-16.
43. Honkanen P.O., Keistinen T., and Kivela S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 15 (1997) 317-320
44. Martin L.M., Leff M., Calonge N., Garrett C., and Nelson D.E. Validation of self-reported chronic conditions and health services in a managed care population. Am. J. Prev. Med. 18 (2000) 15-18
45. Haapanen N., Miilunpalo S., Pasanen M., Oja P., and Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am. J. Epidemiol. 145 (1997) 762-769
46. Kehoe R., Wu S.Y., Leske M.C., and Chylack Jr. L.T. Comparing self-reported and physician-reported medical history. Am. J. Epidemiol. 139 (1994) 813-818
47. O'Connor P.J., Rush W.A., Pronk N.P., and Cherney L.M. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am. J. Manage. Care 4 (1998) 335-342
48. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-524
49. Muñiz J. Effect of the application of the new diagnostic of diabetes mellitus in the prevalence estimates and diagnostic level in the general population. Eur. J. Public Health 9 (1999) 149-151
50. M. Ruiz-Ramos, A. Escolar-Pujolar, E. Mayoral-Sanchez, F. Corral-San Laureano, I. Fernandez-Fernandezc, [Mellitus diabetes in Spain: death rates, prevalence, impact, costs and inequalities.]Gac. Sanit. 20 (Suppl 1.) (2006) 15-24.
51. Bowlin S.J., Morrill B.D., Nafziger A.N., Jenkins P.L., Lewis C., and Pearson T.A. Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey. J. Clin. Epidemiol. 46 (1993) 561-571
52. Masia R., Sala J., Rohlfs I., Piulats R., Manresa J.M., and Marrugat J. Investigadores del estudio REGICOR. [Prevalence of diabetes mellitus in the province of Girona] Spain: the REGICOR study] Spanish. Rev. Esp. Cardiol. 57 (2004) 261-264
53. Botas Cervero P., Delgado Alvarez E., Castano Fernandez G., Diaz De Grenu C., Prieto Santiago J., and Diaz Cadorniga F.J. [Prevalence of diabetes mellitus and glucose intolerance in the population aged 30 to 75 years in Asturias, Spain] Spanish. Rev. Clin. Esp. 202 (2002) 421-429
54. The Decode Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts, Diabetes Care 26 (2003) 61-69.
55. Castell C., Tresserras R., Serra J., Goday A., Lloveras G., and Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diab. Res. Clin. Pract. 43 (1999) 33-40
56. Mac Donald R., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am. J. Prev. Med. 16 (1999) 173-177
57. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., and Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 21 (2003) 1486-1491
58. Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003, Vaccine 23 (2005) 5133-5143.